1 active not recruiting, 1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Inotuzumab Ozogamicin: new trials by email Literature Review of Inotuzumab Ozogamicin trials Research Report on Inotuzumab Ozogamicin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy Blinatumomab and Inotuzumab Ozogamicin - Acute Lymphoblastic Leukemia, Immunotherapy | Phase 2 | Recruiting | The First Affiliated Hospital of Soochow University | 26 | 2025-05-17 | 2026-03-24 |
| A Multi-center Retrospective Study of INO Treating B-ALL Inotuzumab Ozogamicin - Acute Lymphoblastic Leukaemia, Acute Lymphoblastic Leukaemias (ALL) | Active not recruiting | Ruijin Hospital | 102 | 2022-06-01 | 2025-11-25 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2)
Inotuzumab Ozogamicin (2) · blinatumomab (1)
Ruijin Hospital (1) · The First Affiliated Hospital of Soochow University (1)
China (2)